IME Technologies relocates R&D and production facility

Share

IME TechnologiesIME Technologies has relocated its R&D and production facility in the Dutch town of Geldrop to a larger facility in Waalre, near Eindhoven in the Netherlands.

The new building will allow the IME Technologies to make its electro spinning machines autonomously as well as the actual extracellular matrices or scaffolds that are needed for medical implants, the Waalre, the Netherlands–based company said. The company’s technology solutions replicate natural human extracellular matrix for implants in the human body — with replication taking place down to the nanometer level.

IME Technologies plans to officially open the new facility in September of this year.

The Dutch economic development company De Brabantse Ontwikkelings Maatschappij (BOM) and informal investor network TIIN Capital (TIIN) are IME Technologies’ shareholders.

Hear from top executives at Abbott, Google, Boston Scientific, Medtronic and more at DeviceTalks Minnesota, June 4–5 in St. Paul.

Speak Your Mind

*